➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
McKesson
Baxter
Johnson and Johnson

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: apremilast


Email this page to a colleague

« Back to Dashboard

Apremilast

CASRN: 608141-41-9

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Medtronic
Harvard Business School
Express Scripts
Johnson and Johnson